Psychotropic medication use is higher in early‐ than late‐onset Alzheimer’s disease

Psychotropic medication use in Alzheimer’s disease (AD) is important in symptom management as neuropsychiatric symptoms (NPS) often reduced quality of life for both patients and families. The extent to which these medications are prescribed at similar or discrepant rates between those with early symptom onset (EOAD) and late symptom onset (LOAD) is unknown but may have important implicants for clinical care